Image

The Couple in Control

The Couple in Control

Not Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Approximately one-fifth of community dwelling older adults exhibits mild cognitive impairment (MCI), and despite this being an early caregiving role, assisting a person with MCI is stressful and challenging. The purpose of this study is to develop and pilot test a communication-based psychoeducation program for persons with MCI and their care partners to improve their interpersonal management of MCI. The study team will be recruiting 30 adults throughout the US, though predominantly in GA, to serve on a virtual advisory board, which will meet every other week via webinar software to develop a virtual psychoeducation program for care partner dyads.

Description

Approximately one-fifth of community dwelling older adults exhibits mild cognitive impairment (MCI), and despite this being an early caregiving role, assisting a person with MCI is stressful and challenging. The purpose of this study is to develop and pilot test a communication-based psychoeducation program for persons with MCI and their care partners to improve their interpersonal management of MCI. The investigators will be recruiting 30 adults throughout the US, though predominantly in GA, to serve on a virtual advisory board, which will meet every other week via webinar software to develop a virtual psychoeducation program for care partner dyads. Advisory board members will include persons with MCI and care partners for persons with MCI. Advisory Board recruitment will be made directly by investigators via phone or email.

In the second phase of the study, the study team will test the virtual program developed through the advisory board in four groups of 6 MCI/care partner dyads (n=48). Study information and recruitment materials will be sent to neurology partners throughout Georgia to make study information available to any interested patients with MCI. Verbal consent will be obtained by investigators over the phone or through webinar software, and participants will complete surveys through RedCAP software baseline, 4 weeks post-, and 8 weeks post-intervention. A subsample of n=30 intervention participants will be invited to engage in a virtual interview with staff to examine the feasibility and acceptability of their intervention experience. Total respondent burden for advisory board members won't exceed 36 hours; and respondent burden for intervention participants (including those doing interviews) will not exceed 26 hours.

Data will not be made publicly available, and participants will be assigned a coded identifier with the password-protected document containing the key stored separately from data files. Designated study staff will have access to this key. All study files will require a password for access, and only study personnel will have access to the file passwords. Audio recordings will be destroyed following completion of the study and transcription of the interviews. As the study is virtual, all quantitative data will be collected online, and interviews will be conducted through webinar software. The scope of topic areas covered in the advisory board, intervention, and interviews will pertain to experiences, challenges, and coping strategies of persons with MCI and their care partners.

Eligibility

Inclusion Criteria:

  • Dyads composed individuals with a clinician-confirmed diagnosis of MCI and a primary care partner
  • Can read, speak, and understand English
  • Have internet connectivity and a separate zoom-enabled device for each dyad member
  • Dyads must live together, as this will provide sufficient opportunity for intervention homework and communication practice activities.
  • The virtual format of the intervention allows for recruitment of participants throughout the country, including in remote or rural areas.

Exclusion Criteria:

  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners
  • Individuals who are not able to clearly understand and speak English
  • Those living with MCI will need to successfully complete a capacity to consent survey to be included in the study.

Study details
    Mild Cognitive Impairment

NCT05423912

Emory University

5 December 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.